• Medtronic’s commitment to helping people living with diabetes
For over 30 years, Medtronic has led the technology revolution in diabetes care. This history vividly reflects our dedication and ongoing vision to develop an "artificial pancreas". In 1983, we pioneered the idea of continuous insulin delivery, introducing our first insulin pump as the most innovative way to deliver insulin and help manage glucose control for people living with diabetes. 
Since that time, Medtronic has remained a market leader, earning a reputation for excellence in insulin pump technology, continuous glucose monitoring and data management.


At Medtronic, our number one goal is the creation of an artificial pancreas – or a “closed-loop system” – which monitors glucose levels 24/7 and automatically delivers insulin in response.

Any statements made about the company's anticipated regulatory approvals are forward-looking statements subject to risks and uncertainties.